Document Mentions (5 shared documents)

EFTA01295633_sub_001 - EFTA01295633_100

3 mentions1 same-page

Page ?Same page

3d at 1201 (7.95 and 38.03 standard deviations); Lopez v. Laborers Intl Union Local No. 18, 987 F. 2d 1

e Court's dictate in Amgen that a court should engage the merits of a claim only to the extent necessary to verify that Rule 23 has been satisfied. Amgen, 133 S. Ct. at 1194-95. Brown I did precisely that. 1. Even evaluated in a still more painstaking manner, the workers' statistical evidence is me

its of appellants' claim at this stage would be improper." Id. at 156. Such a statement, however, is consistent with the Supreme Court's dictate in Amgen that a court should engage the merits of a claim only to the extent necessary to verify that Rule 23 has been satisfied. Amgen, 133 S. Ct. at 1194-9

EFTA00136746

2 mentions1 same-page

Page ?Same page

ednesday sanctioned "Gen. Luis Alberto Rodriguez Lopez-Calleja, the former son-in-law of Cuban leader Ra

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

EFTA00135712

2 mentions1 same-page

Page ?Same page

ednesday sanctioned "Gen. Luis Alberto Rodriguez Lopez-Calleja, the former son-in-law of Cuban leader Ra

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human